From: Mortality among British Columbians testing for hepatitis C antibody
 |  | MNR vs. SNR | REAC vs. SNR | SERO vs. SNR | SERO vs. MNR | SERO vs. REAC |
---|---|---|---|---|---|---|
ICD-10 | Cause of Death | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) |
A00-R99; V01-Y98 | All | Â | Â | Â | Â | Â |
 | Age <40 | 2.07 (1.82-2.36) | 7.25 (6.54-8.06) | 7.52 (5.85-9.52) | 3.62 (2.79-4.65) | 1.03 (0.80-1.31) |
 | Age ≥40 | 1.42 (1.36-1.49) | 2.39 (2.27-2.51) | 3.36 (2.49-4.41) | 2.36 (1.75-3.11) | 1.41 (1.04-1.85) |
B15-B19; B942; C22; K70-K76 | Liver related | 2.72 (2.34-3.14) | 9.62 (8.55-10.87) | 5.10 (2.30-9.62) | 1.88 (0.85-3.55) | 0.53 (0.24-0.99) |
F11-F16; F19; X40-X44; X60-X64; X85; Y10-Y14 | Drug related | 2.62 (2.11-3.25) | 13.70 (11.76-16.13) | 20.83 (15.15-28.57) | 8.00 (5.71-11.11) | 1.54 (1.12-2.05) |
B20-B24 | HIV related | Â | Â | Â | Â | Â |
 | Female | 3.03 (0.90-9.52) | 83.33 (40.00-200.00) | 52.63 (11.49-200.00) | 17.54 (3.62-71.43) | 0.64 (0.16-1.75) |
 | Male | 1.77 (1.11-2.74) | 12.05 (9.09-16.13) | 10.87 (5.24-20.41) | 6.17 (2.84-12.35) | 0.90 (0.44-1.63) |